Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Proponents often emphasize the potential for substantial therapeutic benefits, especially in diseases where conventional medications have proven limited. However, crucially important to evaluate the considerable financial burden associated with CPI ste